Solvay Pharma India (Delisted) share price history
BSE: 532447
Last traded ₹2,141.55 on 25 Aug 2011
Delisted on 30 Sep 2011.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Aug 2011
11 Aug · Business
Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd. with Abbott India Ltd. ....
Jul 2011
15 Jul · Business
Hon'ble High Court of Bombay, on July 15, 2011, has sanctioned the Scheme of Amalgamation of Solvay Pharma India Limited, the Transferor ....
Jun 2011
30 Jun · Management
With reference to the earlier announcement dated March 29, 2011, regarding Mr. Niteen Gadgil had tendered his resignation as Managing Director of the Company and that he would, continue ....
May 2011
Apr 2011
Results
Standalone; ₹ crore, the charts by years to December, the table by quarter.Quarterly results
Quarter to Mar 2011, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹81 Crup 6.39%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹11 Crup 62.23%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 13.9%
Revenue by year
Peak revenue ₹297 Cr, year to Dec 2010
Net profit by year, a loss in red
| ₹ crore | Jun 2009 | Sep 2009 | Dec 2009 | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 62.3 | 63.8 | 67.0 | 62.7 | 73.9 | 84.2 | 76.0 | 80.9 |
| Net profit | 10.8 | 11.2 | 10.5 | 11.3 | 15.4 | 17.2 | 6.9 | 11.2 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 17.3% | 17.6% | 15.6% | 18.0% | 20.8% | 20.5% | 9.1% | 13.9% |
Standalone. The last eight quarters. The latest is shaded.
Where the return came from
Yearly rates to Dec 2010, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +13.9% | – | – | 0.0% |
| 3 years | +41.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Recent sessions
The last 10 trading days to 25 Aug 2011, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 25 Aug 2011 | 2,150.00 | 2,150.00 | 2,140.00 | 2,141.55 | – | 81 |
| 24 Aug 2011 | 2,165.00 | 2,179.00 | 2,127.80 | 2,136.35 | – | 92 |
| 23 Aug 2011 | 2,100.10 | 2,164.00 | 2,100.10 | 2,164.00 | – | 32 |
| 22 Aug 2011 | 2,120.00 | 2,153.00 | 2,107.50 | 2,149.90 | – | 62 |
| 19 Aug 2011 | 2,154.80 | 2,154.80 | 2,080.50 | 2,087.05 | – | 21 |
| 18 Aug 2011 | 2,095.25 | 2,149.90 | 2,063.00 | 2,110.30 | 2,100.94 | 391 |
| 17 Aug 2011 | 2,100.00 | 2,100.00 | 2,031.20 | 2,097.75 | 2,094.10 | 222 |
| 16 Aug 2011 | 2,098.00 | 2,098.00 | 2,052.00 | 2,054.35 | – | 54 |
| 12 Aug 2011 | 2,137.80 | 2,137.80 | 2,060.00 | 2,060.00 | 2,090.58 | 121 |
| 11 Aug 2011 | 2,099.00 | 2,125.00 | 2,085.50 | 2,100.10 | – | 46 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Solvay Pharma India Ltd.
- BSE code
- 532447
- ISIN
- INE593D01010
- Face value
- ₹10